# Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

> **NCT00520741** · PHASE3 · COMPLETED · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 426 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide
- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT00520741
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 426 (ACTUAL)
- **Last updated:** 2018-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520741, "Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00520741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*